Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum]
Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087–2094.On page 2089, a column heading in Table 1 was incorrectly presented. The last column heading was presented as “Golimumab 60 mg”, whereas this should have been presented as “Golimu...
Main Authors: | Toussirot E, Vauchy C, Binda D, Michel F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-01-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/corrigendum-radiographic-and-nonradiographic-axial-spondyloarthr-peer-reviewed-article-DDDT |
Similar Items
-
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
by: Toussirot E, et al.
Published: (2016-07-01) -
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016-07-01) -
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
by: Nilasha Ghosh, et al.
Published: (2017-12-01) -
Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease
by: Marina Magrey, MD, et al.
Published: (2022-04-01) -
Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis
by: Anna Neumann, et al.
Published: (2018-08-01)